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Photoaffinity-labeled N-formyl chemotactic peptide 
receptors from human neutrophils solubilized in octyl 
glucoside exhibit two forms upon sucrose density gra-
dient sedimentation, with apparent Sedimentation 
coefficients of approximately 4 and 7 S. Tbe 7 S form 
can be converted to the 4 S form by guanosine 5' -0-
(3-thiotriphosphate) (GTP-yS) with an EC&o of -20 nM, 
suggesting that the 7 S form may represent a physical 
complex of the receptor with endogenous G protein 
(Jesaitis, A. J., Tolley, J. 0., Bokoch, G. M., and Allen, 
R. A. (1989) J. Cell Biol. 109, 2783-2790). To probe 
the nature of the 7 S form, we reconstituted the 7 S 
form from the 4 S form by adding purified G protein. 
The 4 S form, obtained by solubilizing GTP-yS-treated 
neutrophil plasma membranes, was incubated with pu-
rified (>95%) G. protein from bovine brain (containing 
both G1a1 and Gta2) or with neutrophil G protein (Ga), 
and formation of the 7 S complex was analyzed on 
sucrose density gradients. The EC&o of 7 S complex 
formation induced by the two G proteins was 70 ::!:: 25 
and 170 :t 40 DM for Ga and G., respectively. No com-
plexation was measurable when bovine transducin (Gt) 
was used up to 30 times the EC&o for Ga. The EC&o for 
Gt was the same for receptors, obtained from formyl 
peptide-stimulated or unstimulated cells. The addition 
of 10 I'M GTP-yS to the reconstituted 7 S complex 
caused a complete reversion of the receptor to the 4 S 
form, and anti-G1 peptide antisera immunosedimented 
the 7 S form. ADP-ribosylation of Gt prevented for-
mation of the 7 S form even at 20 times the concentra-
tion of unribosylated G. normally used to attain 50% 
conversion to the 7 S form. These observations suggest 
that the 7 S species is a pbysical complex containing 
N-formyl chemotactic peptide receptor and G protein. 
The binding of N-formyl peptides to specific cell surface 
receptors (1-3) on human leukocytes results in the activation 
of a variety of cell functions, including chemotaxis, lysosomal 
enzyme secretion, and superoxide production (4). There is a 
substantiaJ body of evidence suggesting that the receptor for 
thesepeptidesmediates transduction through interaction with 
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a guanyl nucleotide-binding protein or G protein (5-7). The 
N-formyl chemotactic peptide receptors in membranes (8) or 
permeabilized neutrophils (9) exist in a high affinity state for 
agonist that can be specifically converted to a low affinity 
state by guanyl nucleotides. It has also been shown that 
GTP-yS1 inhibits high affinity binding of fMet-Leu-[3H]Phe 
to fMet-Leu-Phe receptors with an EC5o value of about 20 nM 
(10). Wehave recently (11) presented data that indicate that 
the octyl glucoside-solubilized N-formyl chemotactic peptide 
receptor from unstimulated neutrophils exhibits two forms 
with apparent sedimentation coefficients of approximately 4 
and 7 S. The 7 S form could be converted to the 4 S form by 
GTP-yS with an EC5o value of about 20 nM, suggesting that 
the 7 S form represented a receptor-G protein complex. The 
inhibition of high affinity agonist binding to G protein cou-
pled-receptors by guanyl nucleotides is generally accepted to 
be indicative of uncoupling of receptor and G protein ( 5). The 
similar GTP-yS concentration dependence of the 7 to 4 S 
conversion (11) and the inhibition of high affmity agonist 
binding by GTP-yS (10) further substantiates that the 7 S 
form of the fM:et-Leu-Phe receptor represented the G protein-
coupled form. 
Pertussis toxin-catalyzed ADP-ribosylation of a 40-kDa 
membrane substrate in neutrophils also disrupts the func-
tional coupling of the N-formyl chemotactic peptide receptor 
to neutrophil activation (12). The cholera toxin-induced 
ADP-ribosylation of this substrate in membranes can be 
modulated by N-formyl peptide binding (13, 14), suggesting 
an interaction with the ligand-occupied receptor. Finally, 
chemotactic N-formyl peptides stimulate guanyl nucleotide 
binding and pertussis toxin-sensitive GTPase activity in the 
neutrophil membranes (15, 16). The molecular mechanisms 
of the uncoupling however, remain unclear. 
Pertussistoxinsubstrates of 40 and 41 kDa in neutrophils 
and HL60 cells have been purified and appear tobe identical 
with Gi2 and Gia (17-19). Gi2 (also termed Gn) has been shown 
tobe the majorsubstratein maturehuman neutrophils (20) 
and HL60 cells (18, 21). Both Gi2 and Gia have been demon-
strated to be functionally coupled to N-formyl chemotactic 
peptide receptors in HL60 cells (21). Several studies have 
demonstrated that high affinity formyl peptide binding, for-
myl peptide-stimulated GTPase activity, and formyl peptide-
mediated activation of phospholipase C (22, 23) can be re-
1 Tbe abbreviations used are: GTP-yS, guanosine 51 -0-(3-thiotri-
phosphate); SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel 
electrophoresis; Hepes, 4-(2-hydroxyethyl) -1-piperazineethanesul-
fonic seid, SASD, sulfosuccinimidyl-2-(p-azidosalicylamido)ethyl-
1,3 1 -dithiopropionate; FMLPL_t26I -SASD, N- formyl- Met-Leu-Phe-
Lys-N -(2-(p-azido-1261 -salicylamido)ethyl-1,3 1 -dithiopropionate. 
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stored by rat or brain GdGo proteins. These various criteria 
clearly indicated that restoration of function of receptor-G 
protein coupling can be demonstrated. To date, however, there 
has been no demonstration of the formation of a physical 
complex of the N-formyl chemotactic peptide receptor with 
GTP-binding protein(s). 
Active functional receptor G protein complexes have clearly 
been demonstrated in rhodopsin, ß-adrenergic, muscarinic, 
dopamine, and adenosine receptor systems among the many 
now investigated (24). In nearly all cases, evidence for such 
association has been the GTP sensitivity of agonist binding 
(or phototransformation in the case of rhodopsin) or agonist/ 
light-induced stimulation ofthe GTPase activity. In a nurober 
of detergent-based systems (25-28) used for the study of such 
interactions, including the formyl peptide receptor system 
(11, 29), receptors or G proteins have been shown to be 
released from apparent complexation upon exposure to GTP 
or its nonhydrolyzable derivatives. Reconstitution ofthe func-
tional activities described above have also been demonstrated 
in both membrane- and detergent-based systems. To our 
knowledge no studies have reported direct measurement of 
such complexes by hydrodynamic analysis of solubilized ra-
diolabeled receptors. 
In this report, we provide evidence for the direct formation 
of a 7 S complex between 4 S receptors and either pure bovine 
brain Gi or purified endogenaus neutrophil Gn. We addi-
tionally show that stoichiometric ADP-ribosylation of Gi by 
pertussis toxin prevents the reconstitution of 7 S complexes 
with G protein. Moreover, the structurally related G protein 
of the visual system, Gh does not reconstitute a 7 S complex, 
indicating specificity of the receptor for Gn and Gj. These 
observations suggest that the 7 S complexes are the result of 
physical association of receptor and G protein, whereas the 4 
S form is uncoupled from G proteins. 
MATERIALS AND METHODS 
Buffers, chemicals, and methods of cell preparation were as previ-
ously described (11, 30). Chemieals used for G protein isolation were 
as described by Bokoch et al. (20, 31). Anti-G protein antisera were 
prepared as described in Ref. 20. 
ldenti{ication of 4 or 7 S forms of N-formyl Chemotactic Peptide 
Receptor-Plasma membrane fractions were prepared from degranu-
lated neutrophils as described previously by Parkos et al. (30). The 
N-formyl chemotactic peptide receptors were specifically labeled with 
FMLPL-1261-8A8D by the procedu.res of Allen et al. (32, 33). In order 
to prevent isolation of endogenaus 7 S receptor forms during the 
membrane solubilization and reconstitution step, the labeled mem-
branes were treated with 10 JJM GTP'YS and were subsequently 
washed with "relax buffer" (10 mM Hepes, pH 7.4, 100 mM KCl, 10 
mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 pg/ 
ml chymostatin, containing 1.0 M NaCl). Labeled membranes were 
pelleted and resuspended at 0.5-0.8 mg of protein/ml in the relax 
buffer containing 1.0% 1-octyl-ß-D-glucopyranoside (octyl glucoside) 
and then incubated on ice for 2 h. Insoluble material was removed by 
sedimentation at 45,000 rpm in a Beckman 60Ti rotor for 30 min at 
4 oc. 8upernatant extracts (100 JJl} were layered onto 5-ml 5-20% 
linear sucrose density gradients prepared in the extraction buffer. 
Gradients were centrifuged in an 8W 55 Beckman swinging bucket 
rotor for 16 h at 45,000 rpm and fractionated into 13 X 400-JJI 
fractions. Alternatively, to conserve material and reduce sedimenta-
tion time, experiments were also carried out using 25-JJl samples on 
0.7-ml gradients sedimenting for 8 h in the same rotors. In some 
cases, fractions were diluted 1:10 in extraction buffer, concentrated 
to the .original volume, and resedimented by the first procedure. 
Sedimentation was calibrated with known protein standards by cen-
trifuging a mixture containing 25 JJg each of cytochrome c (2.1 8), 
bovine serum albumin (4.4 8), porcine immunoglobulin (7.7 S), and 
bovine catalase (11.2 8) in parallel with the experimental gradients. 
Photoaffinity-labeled receptor content was measured by autoradiog-
raphy ofreceptors separated on 8D8-PAGE or by the 1~1 content of 
fractions, as described previously (11). 
Reconstitution of Receptor with G Protein and Analysis-Octyl 
glucoside extracts were divided into individual incubation mixtures 
with the indicated Ievels of G protein under the conditions described 
in the text. Incubations were carried out for 2 h on ice. Sampies were 
then layered onto 5-ml 5-20% linear sucrose gradients, and receptor 
sedimentationwas analyzed as described above. The G protein con-
centration dependence of the reconstitution of the 7 S form of the 
receptor was fitted with the Hill equation using a nonlinear non· 
weighted curve-fitting computerprogram (34). Endogeneous G pro-
tein did not couple with the receptor, as evidenced by the identical 
sedimentation pattem at zero G protein in the presence of 10 JJM 
GTP'YS. 
Preparation of G Proteins-Gi was purified from bovine brain as 
described (35) and resolved from Go by chromatography on a 20-ml 
DEAE-Sephacel column equilibrated with 25 mM Tris-HCI, pH 8, 1 
mM EDTA,1 mM NaCI, 0.6% Lubrol, andeluted with a linear gradient 
(200 ml) of 0-250 mM NaCl in the same buffer. Purity was judged to 
be 95% or higher, as assessed by SD8-PAGE and silver staining. 
Concentrations given for the G proteins are based on the protein 
concentration determined after the final elution step. The G proteins 
used were functionally intact, as determined by [36S]GTP'YS binding 
(20). Neutrophil Gn (or Gi2) was isolated as described by Bokoch et 
al. (20, 31) up until the heptylamine-Sepharose chromatography, with 
the e:X:ception that purifications were performed in the absence of 
AlCla, MgC12, and NaF. The Gn was further purified to apparent 
homogeneity by DEAE-Sephacel chromatography as described above, 
concentrated by hydroxyapatite chromatography, and switched into 
Lubrol-containing buffers by G-25 gel filtration, as described in Ref. 
36. Functional bovine transducin, able · to stabilize the Meta· li form 
of rhodopsin, was prepared by the method of Stryer et al. (37) and 
was the kind gift of Dr. H. Hamm (Department of Physiology and 
Biophysics, University of Illinois at Chicago College of Medicine). 
ADP-ribosylated Gi was prepared by incubation of 350 JJg of Gi 
with 20 JJg/ml pertussis toxin in 100 mM Tris-HCI, pH 8, 1 mM 
EDTA, 2.5 mM MgCl2, 10 mM thymidine, 1 mM ATP, 0.1 mM GTP, 
0.5 mM dimyristoyl phosphatidylcholine, 10 mM dithiothreitol, and 2 
mM NAD for 30 min at 30 ·c. The level of ADP-ribosylation of the 
Gi was assessed with a parallel incubation in the presence of [32P) 
NAD (specific activity, 300 cpm/pmol) that was analyzed by trichlo-
roacetic acid precipitation/filtration, as in Ref. 36, as well as by 
subsequent [32P]NAD labeling ofthe Gi preribosylated with unlabeled 
NAD (see Fig. 4, inset). Determination of [35S)GTPyS binding to Gi 
and Amido Black protein analyses were as described in Bokoch et al. 
(36). 
RESULTS 
In detergent (Triton X-100 and digitonin), the covalently 
liganded N-formyl chemotactic peptide receptor from human 
neutrophils behaves as a monodisperse species of -63 kDa 
upon Sedimentation equilibrium analysis (38). The receptor 
from differentiated HL60 cells eluted in deoxycholate as a 
-66-kDa species upon gel filtration (29). These estimates are 
consistent with the apparent size ofthe affinity-labeled recep-
tor upon reduced SOS-PAGE, where the liganded receptor 
migrates as a broad band of 50-70 kDa (38-40). lt has been 
demonstrated that the octyl glucoside-solubilized N-formyl 
chemotactic peptide receptor retains the capability for inter-
action with endogenous neutrophil G protein(s) upon recon-
stitution into phospholipid vesicles (41). 
We have previously shown that the photoaffinity-labeled, 
octyl glucoside-solubilized N-formyl peptide receptor from 
human neutrophils exhibits two forms upon sucrose density 
gradient sedimentation, with apparent sedimentation coeffi-
cients of approximately 4 and 7 S (11). The 7 S form could 
be converted to the 4 S form by GTP-yS with an EC60 of -20 
nM, and this size change in the receptor appeared to correlate 
with a reduction in sedimentation rate of Gn a and ß subunits. 
These data suggested that the 7 S form of the N-formyl 
chemotactic peptide receptor might represent a physical com· 
plex with endogenous Gn protein (11). 
To show that the 7 S form is indeed a complex of 4 S 
receptor and Gn, we attempted its reconstitution with purified 
Gn (20, 31). The 4 S form ofthe photoaffinity-labeled receptor 
7578 Pertussis Toxin Inhibits Chemotactic Receptor-G Protein Association 
was isolated from GTP')'S-treated neutrophil membranes by 
octyl glucoside extraction and was incubated with different 
concenti'atio:ns (10-600· nM) of purified Gn. Each incubation 
was subsequently analyzed on a velocity sucrose density gra-
die:nt, and a representative experiment is shown in Fig. 1. It 
can be clearly seen that there is a major shift of receptors 
(identified autoradi0graphically (11} and quantita:ted densi-
tometrically) from the 4 S forlll (peak fra~tion 4) to the 7 S 
form (peakftaction 7).A small percenta.ge ofreceptor (7-8%) 
did not. undergo the.shift. The reconstituted 7 S rec!=lpt<>rform 
was fully s·ensitive to guanyl .nucleotides, as no such shift was 
deteetable in the presence of GTP'YS (see Fig. 4). In addition, 
the reconstituted 7 S form could be reversed to the 4 S form 
when incubated witb GTP')'S. Resedimentation of the pea:k 
or flanking fra:ctions from the zero G protein conditio:n re.-
sulted in distributions virtually indistingliishable (not shown) 
from the original pr<>file, suggesting that the distribu~ions 
were representative of unassociated receptor. 
SOS-PAGE analysis ofthese gradients confirmedthe pres-
ence of Gn. in these 7 S fractiorts (not shown), as had been 
previously shown by W ~stern blot analysis of the endogenpus 
7 S complexes (11). Moreover, when 1:8 anti-G protein anti-
serum (11, 12) was included in similar gradients andin the 
reconstitution mixture containing 300 ilM Git about 30% of 
the receptor in the 7 S fractibn was shifted into fractions 9 S 
and higher, whereas less than 1% was .shifted when equal 
amounts of prebleed control serum were added. Together, 
these results suggest that the 7 S form of the N..cformyl 
chemotactic peptide teceptor may be a physical complex of 
receptor and G protein. 
Autoradiographie analysis of SDS-PAGE gels of each frac-
tion of these runs confirmed that a major portion of the 
radioactivity measured was derived from receptor. F;ig: 2A 
shows the shift in Sedimentation position of the 4 S receptor 
to the 7 S reconstituted receptor-G protein complex at a Gn 
concentration of 200 nM. The two autoradiograms indicated 
that the receptor was shifted in position (not molecular 
weight) in the sedimentation profile and relative to the "in-
ternal standard" of nonspecifically labeled 68-kDa SASD-
binding protein (32, 33}, the a:mount of which varied in the 
preparation dependlng on the age of the Iigand and membrane 
batch used. 
To evaluate the selectivity ofthe receptorfor its·endogenous 
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FIG. 1. Reconstitution of 7 S N-formyl chemotactic peptide 
receptor complexes with purified human neutrophil Gn. Octyl 
glucoside-extracted, photoaffinity-labeled N-formyl chemotactic pep-
tide receptot was incublited with different concentra:tions of Gn, as 
described under "Materillls and Methods." The mixtures were sedi-
mented in an uitracentrifuge for 16 hat 192,000 x gav and fra:ctionated 
into 13 equal fractions. The receptor content öf ea:ch fraction evalu-
ated densitometricallyis plottedas a function ofthe fraction number. 
The 4 and 1 8 niigtatiort distances correspond to fractions 5 and 1, 
respectively. The cörtcentrations of Gn were 0 (Ö), iO (e), 1b0 (ö), 
200 (;&),. 400 (0), and 600 nM <•>· · · · · · -· · · 
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FIG. 2. Autoradiograms of 1251 affinity-la.beled and recon-
sHtut.ed formyl ch~~ota~tic pept1de receptor separated on 
sucrose density gradients. A, fractions from the density gradients 
containing the recönstitutions with 0 nM (a) and.200 nM Gn (b) shown 
in Fig. l were solubilized in SDS and run on 9% SDS-polyacrylamide 
gels. The gels were dried and developed for atitoradiography after 7 
days of exposure with Du Pont Cronex Ql1anta IH intensifying screens 
as described originally by Allenet al. (32). The formylpeptide receptor 
is observed as a broad species between the 68- and 43-kDa markers 
in. both a and b. Also detectable is the presence of a nonspecifically 
labeled 68-kDa SASD-binding protein, which serves as an internal 
sedimentation standard (3.5 S) and is variably present in membrane 
batch ahd Iigand age. 
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FIG. 3. Qu~ntUative comparison of the .ability of Gn~ Gh or 
Gt to recoiistitute a N.;..formyl peptide .receptor G protein com-
plex. Reconstitution analyses as described in Fig. 1 were used to 
determine the ~vidity of N-formyl peptide receptor for G protein.by 
measuring the increase in the 7 S · form as a percentage of the 
saturation value observed with excess G protein. 0; Gn. (n = 3); e, Gi 
(n = 6); .,. Gt (n = 2). 
G-protein transduction partner Gn versus 'G p·roteins from 
other sources, a similar analysis was performed using Gi 
purified from bovine brain (consisting of Gu and Giz (42)), 
andtra-nsducin (Gt) from retina. Averaging ofthe results from 
multiple sedimentation runs permitted \lS to estimate the 
amou;nt of hrain Gi or rteutrophil Gn. necessary to cönvert 50% 
of the 4 S receptor form to the 7 S form (Fig. 3). The EC6o for 
reconstitution of the 7 S form of the receptor was 170 ± 40 
nM for Gi and 70 ± 25 nM for Gn, based on a computer 
calculated fit of the data to the Hili equation (34). Function-
ally activebovinetransducin (Gt) was incapable ofcomplexing 
with the formyl peptide chemotactic receptor in this system, 
as it ~howed no shift in receptor sedimentation rate even at 5 
J.LM added transducin. It_ is noteworthy that the EC5o for the 
reconstitution of the 7 S form of the receptor-G, protein 
complex wa.s the same when using receptors obtained from 
membranes of unstimulated neutrophils and were compared 
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with receptors obtained from agonist-stimulated cells. 
Evidence for the functional significance of the reconstitu-
tion of the pbysical interaction of receptors and G proteins is 
obtained by determining tbe ability of the receptor to recon-
stitute with ADP-ribosylated G protein. Pertussis toxin-cat-
alyzed ADP-ribosylation of Gi proteins is known to uncouple 
the Gi protein from their receptor transduction partners (5). 
This uncoupling has been demonstrated by examining recep-
tor-stimulated functions in intact cells, membranes, or recon-
stituted systems, including phospholipase C activation (23), 
adenylate cyclase inhibition (43), receptor-stimulated GTPase 
activity (16, 44), and high affinity agonist binding to the N-
formyl chemotactic peptide receptor (16), and by other means 
(44, 45). However, physical uncoupling of receptor and G 
proteins by ADP-ribosylation has not, to our knowledge, been 
demonstrated. Indeed, one can postulate that functional un-
coupling could take place without physical disruption of the 
receptor-G complex. We therefore examined the ability of 
ADP-ribosylated Gi to reconstitute the N-formyl chemotactic 
peptide receptor-G protein (7 8) complex. 
TableI documents the preparation of ADP-ribosylated Gj. 
The proteinwas ADP-ribosylated to an extent of 0.96 pmol 
of ADP-ribose/pmol of GTP-yS binding, as determined by 
direct analysis of [32P]NAD incorporation. Tbat the protein 
was totally ADP-ribosylated is also shown by the inability to 
significantly Iabel witb [32P)NAD subsequent to initial ADP-
ribosylation with unlabeled NAD (Fig. 4, inset). In order to 
confirm that the ADP-ribosylated Gi was still functional after 
the ADP-ribosylation reaction, we determined (see Table I) 
that GTP-yS binding to tbe ribosylated Gi reacbed a Ievel of 
0.9 pmol of GTP-yS/pmol of protein, which is the same value 
obtained with the nonribosylated (control) protein. 
As shown in Fig. 4, when the stoichiometrically ADP-
ribosylated Gi protein was used to attempt reconstitution of 
the N-formyl chemotactic peptide receptor-G protein (7 S) 
complex, we were not able to sbift the 4 S receptor to the 
faster sedimenting form. Even though we raised the concen-
tration of ADP-ribosylated Gi to 20 times tbe concentration 
that resulted in 50% complexation of receptor by control Gi, 
receptor Sedimentation profiles showed no conversion of 
receptor to the 7 S form. These data suggest that the pertussis 
toxin-catalyzed ADP-ribosylation of G proteins prevents their 
physical complexation with receptors. This result also sug-
gests that previous studies showing only partial uncoupling 
by tbe 14-amino acid peptide mastoparan as a receptor analog 
(40) is not fully representative of complete receptor-G protein 
interaction. 
DISCUSSION 
In this study, we demonstrated that the sedimentationrate 
of octyl glucoside-solubilized N-formyl chemotactic peptide 
receptor was increased wben incubated with either the endog-
enaus neutrophil pertussis toxin substrate, Gm or purified Gi 
protein(s) from bovine brain but was unchanged when incu-
bated with bovine transducin. These changes were prevented 
by guanine nucleotides and, in the case of bovine Gh by 
pertussis toxin-catalyzed ADP-ribosylation. The most likely 
explanation for these observations is that the 7 S form of the 
receptor is a physical complex containing the heterotrimeric 
G protein and receptor. Although it is conceivable that such 
a change could result from a G protein-dependent oligomeri-
zation of the receptor with itself or other proteins, it is highly 
unlikely for several reasons. First, our results are consistent 
with the large body of biochemical evidence measuring func-
tional parameters, such as agonist binding, GTPase activity, 
and phototransformation observed in many receptor systems 
and interpreted as evidence for complexation of receptors and 
G proteins (24). Second, a G protein-dependent oligomeriza-
tion of receptors with other proteins would necessarily imply 
that the newly formed complex would bave to interact with 
G proteins again in the GTP-bound form in order to explain 
the sensitivity of the 7 S form to guanyl nucleotides. Evidence 
for a second collisional interaction of receptor and G protein 
does not exist. Finally, our data indicating specific immuno-
sedimentation of receptor by anti -G protein antisera, suggests 
that stable receptor G-protein complexes have been formed. 
The 4 and 7 S forms of the N-formyl chemotactic peptide 
receptor appears relatively broad in Figs. 1 and 2 (half-band 
width, -35% of gradient) in contrast to other membrane 
proteins (half-band width, 15-20%) (46, 47). Such broadening 
could arise from a number of sources, including heterogeneaus 
glycosylation ofreceptor (48), variable amounts ofbound Iipid 
and/or detergent on this very hydrophobic protein (38), or 
even the presence of oligomeric forms of the receptor (49) or 
other proteins (50). Resedimentation of receptors in the peak 
and flanking fractions of the 4 S form (zero G protein runs) 
indicate that the distributions do not narrow or shift in 
position, suggesting that these latter two possibilities are 
unlikely. Technical considerations, such as anomalous zone 
broadening, wall effects, and diffusion (51), are sufficient to 
explain the broad receptor bands, since narrower distributions 
are observed (half-band width, 12% of gradient) when shorter 
gradients in narrower tubes were used toshorten sedimenta-
tiontime and reduce wall effects (Fig. 4). 
Our reconstitution evidence is also consistent with quanti-
tative estimates of requirement for functional interactions 
within the cell. The N-formyl chemotactic peptide receptor 
was not purified in this work, and we estimate that it was 
present in the starting membranes at a level of 5-10 pmolf 
mg of membrane protein. Endogenous Gn protein was present 
at a level of -1 nmol of Gna subunit/mg of membrane protein 
(20, 52). Therefore, the amount of total Gna subunit relative 
to receptor was approximately 100 to 1 in the native mem-
brane. If one makes the assumption that only the aß-y complex 
of Gn is able to effectively interact with receptor, this ratio is 
reduced to 25 to 1, since ß"Y subunits appear to be present at 
Ievels approximately one-fourth that of a subunits (20). We 
induced approximately 80% of the maximum conversion of 
the labeled receptor from the 4 to the 7 S form (Fig. 3) at 300 
pmolfml Gn. This Ievel is similar to the Ievel of the oligomeric 
Gn that is present in the native membrane. W e are not using 
a huge excess of G protein relative to what exists in the cell 
TABLE 1 
Characterization of G; ADP-ribosylation by Pertussis Toxin 
ADP-ri-
Sample Protein GTPyS GTPyS/ bose in- ADPr/ ADPr/ bound protein corpo- protein GTPyS 
rated 
pmol/ml pmol/ml pmolfpmol pmol/ml pmol/pmol pmol/pmol 
Control Gi 0.495 0.470 0.95 
ADP-ribosylated Gi 2.66 2.34 0.88 2.24 0.84 0.96 
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FIG. 4. ADP-ribosylated Gi is incapable of forming pbysical 
complexes with the N-formyl peptide receptor. Reconstitution 
of the receptor was attempted with 400 nM G; + 10 ~M GTP-yS (0), 
400 nM G; (e), and 3000 rtM ADP-ribosylated G; <•), as performed 
in Fig. 1, except that this sedimentati.on was performed in smaller 
tubes (or shorter times (8 h). The percent of the total sedimentable 
radioactivity in the gradien·t is plotted as a furtction of fraction 
number of the octyl glucoside-containing velodty sucrose gradient. 
The inset shows the labeling of either control (c) or pre.;ADP-
ribosylated G; (r) (as described in Table I) with [32P]NAD and 
pertussis toxin. The autoradiögram was overexposed to demonstrate 
that all of the G; protein was stoichiometrically ADP-ribosylated by 
the initial (cold) ADP-ribosylation reaction (see "Materials and 
Methods"). 
to achieve the reconstitution of the receptor-G complex in 
uitro. Both in vitro and in vivo the G protein Ievels are 
considerably in excess (>100-fold) of the N-formyl peptide 
receptor itself. 
The similar values for the ECso for complex formation seen 
with the brain and neutrophil G proteins may reflect identical 
efficiency in the coupling of Gn and the G;2 portion present in 
the mixed brain G; preparation. Our experiments, however, 
are not able to determine if the receptor interacts with both 
G;1 and G;2 in the brain preparation. At least three polypeptide 
stretches of the a subunit of Gi2 and Gn (corresponding to 
residues 8-23, 311-328, and 340-350 of transducin) may be 
interacting with receptors based on an analogy from peptide 
competition studies ofthe interaction of rhodopsin and trans-
ducin (53, 54). The a subunits of bovine G;2 and human Gn 
are 100% identical in these stretches. The identity between 
the a subunits of Gn and Gil in these regions is 87, 100, and 
100%, respectively. The overall identity of G;1 and G;2 a 
subunits, moreover, is 90%, suggesting the differences are 
rather small but significant. Transducin, which does not 
interact with the formyl peptide receptor, has a sequence that 
is only 44, 78, and 91% identical with Gn in the above 
polypeptide regions. Although these regions are 88, 83, and 
100% homologous, if conservative substitutions are consid-
ered, there appears to be insufficient similarity to allow trans-
ducin to interact with the human chemotactic receptor. These 
results therefore suggest that the 7 S complex formation is 
selective and can recognize structural differences in G pro-
teins. Thus, the methods described in this report should be 
suitable for deta:iled sturlies of the specificity of interaction of 
the N-formyl peptide receptor with various other forms of G 
proteins. · 
The technique might also be applicable to investigations of 
functional modification of receptor. Results from our Iabara-
tory using labelad N-formyl peptide receptor prepared from 
unstimulated cells indicate that its Interaction with G protein 
is as avid a.s the receptor prepared from stimulated cells 
described in this study (data not shown). If it can be shown 
that the receptor from desensitized ~ells and unstirnulated or 
stimulated cells .are basically eq1.1ivalent in their affinity for 
G protein, then it would support the hypothesis that the 
lateral segrega.tion of receptor from its transduction partner 
in the plane of the plasma membrane (11, 55) may be suffi· 
cient to explain receptor specific desensitization in neutro-
phils. 
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